ArticleInternational journal of medical sciences2018
Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.
José M Benito, Julia Hillung, Clara Restrepo, José M Cuevas, Agathe León, Ezequiel Ruiz-Mateos, Rosario Palacios-Muñoz, Miguel Górgolas, Rafael Sanjuán, Norma Rallón
Article in International journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 8 institutions in 1 country.
José M BenitoInstituto de Investigación Sanitaria-Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Spain.
Julia HillungInstitute for Integrative Systems Biology (I2SysBio), Universitat de València and Consejo Superior de Investigaciones Científicas, València, Spain.
Clara RestrepoInstituto de Investigación Sanitaria-Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Spain.
José M CuevasInstitute for Integrative Systems Biology (I2SysBio), Universitat de València and Consejo Superior de Investigaciones Científicas, València, Spain.
Agathe LeónHospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
Ezequiel Ruiz-MateosBiomedicine Institute of Seville (IBiS), Sevilla, Spain.
Rosario Palacios-MuñozUnidad de E. Infecciosas. Hospital Virgen de la Victoria e IBIMA, Málaga, Spain.
Miguel GórgolasHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Rafael SanjuánInstitute for Integrative Systems Biology (I2SysBio), Universitat de València and Consejo Superior de Investigaciones Científicas, València, Spain.
Norma RallónInstituto de Investigación Sanitaria-Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Spain.
Universidad Autónoma de Madrid · ESUniversitat de València · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Rey Juan Carlos · ESInstitute for Integrative Systems Biology · ESInstituto de Biomedicina de Sevilla · ES
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients. · full record | OpenQuestion